SLC44A2 and colorectal carcinoma: In this study, we demonstrate that SLC44A2 inhibited the short- and long-term proliferation of CRC cells, as evidenced by both in vitro MTS cell viability, Edu and colony formation assays, and in vivo xenograft tumor growth assay in nude mice.